These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32941198)

  • 1. Outpatient central venous access device insertion in very young children with severe haemophilia.
    Bensadok H; Maniora M; Théron A; Jeziorski E; Rochette A; Navarro R; Schved JF; Champiat MA; Biron-Andreani C
    Blood Coagul Fibrinolysis; 2020 Oct; 31(7):490-492. PubMed ID: 32941198
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term results of central venous access devices in children with haemophilia.
    Upadhyaya M; Richards M; Buckham S; Squire BR
    Pediatr Surg Int; 2009 Jun; 25(6):503-6. PubMed ID: 19455342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable venous access devices in children with severe hemophilia: a tertiary pediatric institutional experience.
    Bedoya MA; Raffini L; Durand R; Acord MR; Srinivasan A; Krishnamurthy G; Vatsky S; Escobar F; Cahill AM
    Pediatr Radiol; 2020 Jul; 50(8):1148-1155. PubMed ID: 32390060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI after removal of central venous access device reveals a high number of asymptomatic thromboses in children with haemophilia.
    Ranta S; Kalajoki-Helmiö T; Pouttu J; Mäkipernaa A
    Haemophilia; 2012 Jul; 18(4):521-6. PubMed ID: 22176603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the use of implantable venous access devices in the management of children with inherited bleeding disorders.
    Komvilaisak P; Connolly B; Naqvi A; Blanchette V
    Haemophilia; 2006 Dec; 12 Suppl 6():87-93. PubMed ID: 17123400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difficult clinical challenges in haemophilia: international experiential perspectives.
    Forsyth AL; Giangrande P; Hay CR; Kenet G; Kessler CM; Knöbl PN; Llinás A; Santagostino E; Young G
    Haemophilia; 2012 Jul; 18 Suppl 5():39-45. PubMed ID: 22757683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Port-a-Caths in the management of paediatric haemophilia.
    Vidler V
    Prof Nurse; 1994 Oct; 10(1):48-50. PubMed ID: 7972182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life-threatening complication of central venous catheter in a child with severe haemophilia A.
    Tomaszewska N; Strzemecka J; Królak A; Zielezińska K; Łaguna P; Pająk JW; Urasiński T; Ociepa T
    Haemophilia; 2023 Jan; 29(1):367-369. PubMed ID: 36399358
    [No Abstract]   [Full Text] [Related]  

  • 9. Central venous access device-related infections in patients with haemophilia.
    Yeoh ZH; Furmedge J; Ekert J; Crameri J; Curtis N; Barnes C
    J Paediatr Child Health; 2013 Mar; 49(3):242-5. PubMed ID: 23438133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of prophylaxis and immune tolerance induction regimens in haemophilic children using fully implantable central venous catheters.
    Mancuso ME; Mannucci PM; Sartori A; Agliardi A; Santagostino E
    Br J Haematol; 2008 May; 141(5):689-95. PubMed ID: 18410458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of short-term central venous catheters for optimizing continuous infusion of coagulation factor concentrate in haemophilia patients undergoing major surgical procedures.
    Boban A; Lambert C; Hermans C
    Haemophilia; 2015 Sep; 21(5):e364-8. PubMed ID: 25982632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central venous access devices in patients with hemophilia.
    Valentino LA; Kapoor M
    Expert Rev Med Devices; 2005 Nov; 2(6):699-711. PubMed ID: 16293097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications of central venous access devices in paediatric haemophilia patients.
    Domm JA; Hudson MG; Janco RL
    Haemophilia; 2003 Jan; 9(1):50-6. PubMed ID: 12558778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central venous access device insertion and perioperative management of patients with severe haemophilia A: a local experience.
    Fonseca A; Nagel K; Decker K; Pukulakatt M; Pai M; Walton M; Chan AK
    Blood Coagul Fibrinolysis; 2016 Mar; 27(2):156-9. PubMed ID: 26340458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of central venous lines in the treatment of chronically ill children.
    Barczykowska E; Szwed-Kolińska M; Wróbel-Bania A; Ślusarz R
    Adv Clin Exp Med; 2014; 23(6):1001-9. PubMed ID: 25618129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Side-effects and venous access issues with immune tolerance therapy.
    Carcao MD
    Haemophilia; 2009 Mar; 15(2):494-500. PubMed ID: 19347990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Port-A-Cath usage in children with haemophilia: experience of 53 cases.
    Ljung R; van den Berg M; Petrini P; Tengborn L; Scheibel E; Kekomäki R; Effenberger W
    Acta Paediatr; 1998 Oct; 87(10):1051-4. PubMed ID: 9825971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing factor prophylaxis for the haemophilia population: where do we stand?
    Blanchette VS; Manco-Johnson M; Santagostino E; Ljung R
    Haemophilia; 2004 Oct; 10 Suppl 4():97-104. PubMed ID: 15479380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of clinical practice on the outcome of central venous access devices in children with haemophilia.
    Khair K; Ranta S; Thomas A; Lindvall K;
    Haemophilia; 2017 Jul; 23(4):e276-e281. PubMed ID: 28544163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central venous access device catheter fragmentation at time of removal in four patients with haemophilia A.
    White S; Jesudas R; Brady TM; Tarantino MD
    Haemophilia; 2019 May; 25(3):e185-e188. PubMed ID: 30817053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.